Antibody avidity satisfies various myeloma In the continued try to find innovative treatments to combat refractory and relapsed most cancers, new preclinical do the job in various myeloma reveals that increasing binding avidity by targeting two antigens in a single T mobile-participating trispecific antibody boosts anti-tumor activity and lowers th